IM4TB Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 3

IM4TB General Information

Description

Developer of tuberculosis drugs intended to focus on developing new treatment options to combat tuberculosis. The company's drug allows the treatment duration to be shortened and substantially diminishes the risks of failure of treatment, relapse of the disease, and increased prevalence of drug-resistance bacteria, enabling clinicians to provide a cure for tuberculosis disease in a pain-free way.

Contact Information

Website
www.im4tb.org
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • EPFL Innovation Park
  • Building I
  • 1015 Lausanne
  • Switzerland
+41 021
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
HealthTech, Life Sciences
Corporate Office
  • EPFL Innovation Park
  • Building I
  • 1015 Lausanne
  • Switzerland
+41 021

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

IM4TB Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Accelerator/Incubator Completed Generating Revenue
4. Grant 01-Sep-2022 Completed Generating Revenue
3. Grant 21-Apr-2017 Completed Startup
2. Grant 16-Mar-2015 $750K Completed Startup
1. Accelerator/Incubator Completed Startup
To view IM4TB’s complete valuation and funding history, request access »

IM4TB Executive Team (2)

Name Title Board Seat
Iain Old Ph.D Operational Director
Gabriel Clerc Vice President & Vice Chairman of the Board
To view IM4TB’s complete executive team members history, request access »

IM4TB Board Members (7)

Name Representing Role Since
Gabriel Clerc IM4TB Vice President & Vice Chairman of the Board
Laurent Fraisse Ph.D Self Board Member
Laurent Nicod MD Self Board Member
Stewart Cole Self Chairman of the Board
Thierry Buclin Self Board Member
You’re viewing 5 of 7 board members. Get the full list »

IM4TB Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Bill & Melinda Gates Foundation Not-For-Profit Venture Capital
Ecole Polytechnique Federale de Lausanne University Minority
EPFL Innovation Park Accelerator/Incubator
To view IM4TB’s complete investors history, request access »

Ready to get started?

Request a free trial

IM4TB FAQs

  • When was IM4TB founded?

    IM4TB was founded in 2013.

  • Where is IM4TB headquartered?

    IM4TB is headquartered in Lausanne, Switzerland.

  • What industry is IM4TB in?

    IM4TB’s primary industry is Drug Discovery.

  • Is IM4TB a private or public company?

    IM4TB is a Private company.

  • What is IM4TB’s current revenue?

    The current revenue for IM4TB is .

  • Who are IM4TB’s investors?

    Bill & Melinda Gates Foundation, Ecole Polytechnique Federale de Lausanne, and EPFL Innovation Park have invested in IM4TB.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »